Please enable JavaScript to continue using this application.

Compare $COYA vs $VTVT | Chartloom

Compare

$COYA vs $VTVT

Coya Therapeutics Inc · vTv Therapeutics Inc

COYA

Coya Therapeutics Inc

VTVT

vTv Therapeutics Inc

Compare $COYA vs $VTVT

Comparing Coya Therapeutics Inc and vTv Therapeutics Inc

COYACoya Therapeutics Inc

VTVTvTv Therapeutics Inc

COYACoya Therapeutics Inc

Market cap

$116M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

35.49x

Rev growth (TTM)

1793.6%

YTD performance

-12.4%

52W performance

-21.6%

FCF yield

-15.3%

VTVTvTv Therapeutics Inc

Market cap

$123M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

216600.0%

YTD performance

-21.3%

52W performance

38.3%

FCF yield

-13.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

COYA

VTVT

Detailed metrics comparison

COYA

Coya Therapeutics Inc

VTVT

vTv Therapeutics Inc

Market Cap

COYA$116M

VTVT$123M

Enterprise Value

COYA$73M

VTVT$36M

Price

COYA$4.95

VTVT$31.18

P/E Ratio

COYAN/A

VTVTN/A

P/S Ratio

COYA14.48x

VTVT3.33x

EV/Sales

COYA9.10x

VTVT0.98x

EV/EBITDA

COYA0.00x

VTVT0.00x

P/B Ratio

COYA2.61x

VTVT1.53x

P/FCF Ratio

COYAN/A

VTVTN/A

EV/FCF

COYA-4.10x

VTVT-2.16x

PEG Ratio

COYAN/A

VTVTN/A

Forward P/E (NTM)

COYAN/A

VTVTN/A

Forward P/S (NTM)

COYA35.49x

VTVTN/A

Revenue (TTM)

COYA$8M

VTVT$37M

Revenue Growth (YoY)

COYA1793.6%

VTVT216600.0%

Forward Rev Growth

COYA389.9%

VTVT-97.3%

Gross Margin (TTM)

COYA0.0%

VTVT0.0%

Operating Margin (TTM)

COYA0.0%

VTVT63.1%

EBITDA Margin (TTM)

COYA-259.8%

VTVT-25.1%

Net Margin (TTM)

COYA-270.2%

VTVT-12.9%

FCF Margin (TTM)

COYA-221.6%

VTVT-45.5%

Net Income (TTM)

COYA$-22M

VTVT$-5M

FCF (TTM)

COYA$-18M

VTVT$-17M

EPS (TTM)

COYA-$0.92

VTVT-$0.38

ROE (TTM)

COYA-5332.0%

VTVT-627.0%

ROA (TTM)

COYA-4748.0%

VTVT-506.0%

ROIC (TTM)

COYA-5332.0%

VTVT-626.0%

Cash

COYA$43M

VTVT$87M

Debt

COYA$0

VTVT$0

Net Cash/Debt

COYA$43M

VTVT$87M

Current Ratio (TTM)

COYA13.40x

VTVT12.48x

Quick Ratio (TTM)

COYA12.29x

VTVT12.42x

Debt/Equity (TTM)

COYA0.00x

VTVT0.00x

Debt/Assets (TTM)

COYA0.0%

VTVT0.0%

Interest Coverage (TTM)

COYAN/A

VTVTN/A

Net Debt/EBITDA (TTM)

COYA0.00x

VTVT0.00x

Beta

COYA0.58

VTVT0.23

52W Performance

COYA-21.6%

VTVT38.3%

YTD Performance

COYA-12.4%

VTVT-21.3%

% from 52W High

COYA-36.1%

VTVT-29.1%

% from 52W Low

COYA33.4%

VTVT59.9%

Asset Turnover (TTM)

COYA0.18x

VTVT0.37x

FCF Yield (TTM)

COYA-15.3%

VTVT-13.6%

Earnings Yield (TTM)

COYA-18.7%

VTVT-3.9%

Dividend Yield (TTM)

COYAN/A

VTVTN/A

Rule of 40

COYA1,571.9

VTVT216,554.5

EV/GP/RG

COYAN/A

VTVTN/A

Ticker research

View COYA research View VTVT research

Metric	COYA Coya Therapeutics Inc	VTVT vTv Therapeutics Inc
Market & Valuation
Market Cap	$116M	$123M
Enterprise Value	$73M	$36M
Price	$4.95	$31.18
P/E Ratio	N/A	N/A
P/S Ratio	14.48x	3.33x
EV/Sales	9.10x	0.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.61x	1.53x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.10x	-2.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	35.49x	N/A
Revenue & Growth
Revenue (TTM)	$8M	$37M
Revenue Growth (YoY)	1793.6%	216600.0%
Forward Rev Growth	389.9%	-97.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	63.1%
EBITDA Margin (TTM)	-259.8%	-25.1%
Net Margin (TTM)	-270.2%	-12.9%
FCF Margin (TTM)	-221.6%	-45.5%
Net Income (TTM)	$-22M	$-5M
FCF (TTM)	$-18M	$-17M
EPS (TTM)	-$0.92	-$0.38
ROE (TTM)	-5332.0%	-627.0%
ROA (TTM)	-4748.0%	-506.0%
ROIC (TTM)	-5332.0%	-626.0%
Financial Health
Cash	$43M	$87M
Debt	$0	$0
Net Cash/Debt	$43M	$87M
Current Ratio (TTM)	13.40x	12.48x
Quick Ratio (TTM)	12.29x	12.42x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	0.23
52W Performance	-21.6%	38.3%
YTD Performance	-12.4%	-21.3%
% from 52W High	-36.1%	-29.1%
% from 52W Low	33.4%	59.9%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.37x
FCF Yield (TTM)	-15.3%	-13.6%
Earnings Yield (TTM)	-18.7%	-3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,571.9	216,554.5
EV/GP/RG	N/A	N/A
Ticker research	View COYA research	View VTVT research

Valuation

P/S Ratio

VTVT

3.33x

COYA

14.48x

EV/FCF

COYA

-4.10x

VTVT

-2.16x

Growth & revenue

Revenue Growth TTM

VTVT

216600.0%

COYA

1793.6%

Forward Revenue Growth

COYA

389.9%

VTVT

-97.3%

Profitability & performance

Gross Margin

COYA

0.0%

VTVT

0.0%

ROE

VTVT

-627.0%

COYA

-5332.0%

FCF Yield %

VTVT

-13.6%

COYA

-15.3%

52-Week Performance

VTVT

38.3%

COYA

-21.6%

Detailed metrics comparison

COYA

Coya Therapeutics Inc

VTVT

vTv Therapeutics Inc

Market Cap

COYA$116M

VTVT$123M

Enterprise Value

COYA$73M

VTVT$36M

Price

COYA$4.95

VTVT$31.18

P/E Ratio

COYAN/A

VTVTN/A

P/S Ratio

COYA14.48x

VTVT3.33x

EV/Sales

COYA9.10x

VTVT0.98x

EV/EBITDA

COYA0.00x

VTVT0.00x

P/B Ratio

COYA2.61x

VTVT1.53x

P/FCF Ratio

COYAN/A

VTVTN/A

EV/FCF

COYA-4.10x

VTVT-2.16x

PEG Ratio

COYAN/A

VTVTN/A

Forward P/E (NTM)

COYAN/A

VTVTN/A

Forward P/S (NTM)

COYA35.49x

VTVTN/A

Revenue (TTM)

COYA$8M

VTVT$37M

Revenue Growth (YoY)

COYA1793.6%

VTVT216600.0%

Forward Rev Growth

COYA389.9%

VTVT-97.3%

Gross Margin (TTM)

COYA0.0%

VTVT0.0%

Operating Margin (TTM)

COYA0.0%

VTVT63.1%

EBITDA Margin (TTM)

COYA-259.8%

VTVT-25.1%

Net Margin (TTM)

COYA-270.2%

VTVT-12.9%

FCF Margin (TTM)

COYA-221.6%

VTVT-45.5%

Net Income (TTM)

COYA$-22M

VTVT$-5M

FCF (TTM)

COYA$-18M

VTVT$-17M

EPS (TTM)

COYA-$0.92

VTVT-$0.38

ROE (TTM)

COYA-5332.0%

VTVT-627.0%

ROA (TTM)

COYA-4748.0%

VTVT-506.0%

ROIC (TTM)

COYA-5332.0%

VTVT-626.0%

Cash

COYA$43M

VTVT$87M

Debt

COYA$0

VTVT$0

Net Cash/Debt

COYA$43M

VTVT$87M

Current Ratio (TTM)

COYA13.40x

VTVT12.48x

Quick Ratio (TTM)

COYA12.29x

VTVT12.42x

Debt/Equity (TTM)

COYA0.00x

VTVT0.00x

Debt/Assets (TTM)

COYA0.0%

VTVT0.0%

Interest Coverage (TTM)

COYAN/A

VTVTN/A

Net Debt/EBITDA (TTM)

COYA0.00x

VTVT0.00x

Beta

COYA0.58

VTVT0.23

52W Performance

COYA-21.6%

VTVT38.3%

YTD Performance

COYA-12.4%

VTVT-21.3%

% from 52W High

COYA-36.1%

VTVT-29.1%

% from 52W Low

COYA33.4%

VTVT59.9%

Asset Turnover (TTM)

COYA0.18x

VTVT0.37x

FCF Yield (TTM)

COYA-15.3%

VTVT-13.6%

Earnings Yield (TTM)

COYA-18.7%

VTVT-3.9%

Dividend Yield (TTM)

COYAN/A

VTVTN/A

Rule of 40

COYA1,571.9

VTVT216,554.5

EV/GP/RG

COYAN/A

VTVTN/A

Ticker research

View COYA research View VTVT research

Metric	COYA Coya Therapeutics Inc	VTVT vTv Therapeutics Inc
Market & Valuation
Market Cap	$116M	$123M
Enterprise Value	$73M	$36M
Price	$4.95	$31.18
P/E Ratio	N/A	N/A
P/S Ratio	14.48x	3.33x
EV/Sales	9.10x	0.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.61x	1.53x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.10x	-2.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	35.49x	N/A
Revenue & Growth
Revenue (TTM)	$8M	$37M
Revenue Growth (YoY)	1793.6%	216600.0%
Forward Rev Growth	389.9%	-97.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	63.1%
EBITDA Margin (TTM)	-259.8%	-25.1%
Net Margin (TTM)	-270.2%	-12.9%
FCF Margin (TTM)	-221.6%	-45.5%
Net Income (TTM)	$-22M	$-5M
FCF (TTM)	$-18M	$-17M
EPS (TTM)	-$0.92	-$0.38
ROE (TTM)	-5332.0%	-627.0%
ROA (TTM)	-4748.0%	-506.0%
ROIC (TTM)	-5332.0%	-626.0%
Financial Health
Cash	$43M	$87M
Debt	$0	$0
Net Cash/Debt	$43M	$87M
Current Ratio (TTM)	13.40x	12.48x
Quick Ratio (TTM)	12.29x	12.42x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	0.23
52W Performance	-21.6%	38.3%
YTD Performance	-12.4%	-21.3%
% from 52W High	-36.1%	-29.1%
% from 52W Low	33.4%	59.9%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.37x
FCF Yield (TTM)	-15.3%	-13.6%
Earnings Yield (TTM)	-18.7%	-3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,571.9	216,554.5
EV/GP/RG	N/A	N/A
Ticker research	View COYA research	View VTVT research